Anti-inflammatory and anti-atherogenic effects of adiponectin in patients with rheumatoid arthritis following anti-TNF therapy

Scandinavian Journal of Rheumatology

Volumn 38, Issue 2, 2009, Pages 158-

  Kapoor, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ADIPONECTIN; CYTOKINE; ETANERCEPT; HIGH DENSITY LIPOPROTEIN; INFLIXIMAB; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ATHEROGENESIS; BLOOD LEVEL; BONE; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; HEART PROTECTION; HORMONE ACTION; HUMAN; INFLAMMATION; LETTER; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ADIPONECTIN; ANIMALS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; HUMANS; IMMUNOGLOBULIN G; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62249093019     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802403713     Document Type: Letter

References (9)

1. Lee SW, Kim JH, Park MC, Park YB, Lee SK. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol 2008;37:260-8.
2. Lewicki M, Kotyla P, Kucharz E. Etanercept increases adiponectin level in woman with rheumatoid arthritis. Clin Rheumatol 2008;27:1337-8.
3. Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, et al. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol 2008;35:936-8.
4. Serelis J, Kontogianni MD, Katsiougiannis S, Bletsa M, Tektonidou MG, Skopouli FN. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol 2008;27:795-7.
5. Huang H, Park PH, McMullen MR, Nagy LE. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J Gastroenterol Hepatol 2008;23(Suppl 1):S50-3.
6. Jacobsson LT, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T, et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:670-5.
7. Yamaguchi N, Kukita T, Li YJ, Kamio N, Fukumoto S, Nonaka K, et al. Adiponectin inhibits induction of TNF-α/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett 2008;582:451-6.
8. Nishida K, Okada Y, Nawata M, Saito K, Tanaka Y. Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J 2008;55:213-16.
9. Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N. Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 2007;17:385-90.